Behavioral pharmacology of the μ/δ opioid glycopeptide MMP2200 in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 3, 2008, Pages 939-948

  Do Carmo, Gail Pereira ^a   Polt, Robin ^b   Bilsky, Edward J ^c   Rice, Kenner C ^d   Negus, S Stevens ^a,e  

^a MCLEAN HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; MMP2200; MORPHINE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTREXONE; NALTRINDOLE; UNCLASSIFIED DRUG; DELTA OPIATE RECEPTOR; GLYCOPEPTIDE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; OPIATE PEPTIDE; TYROSYL-GLYCYL-PHENYLALANYL-LEUCYL-(O-LACTOSYL)SERINAMIDE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG PENETRATION; DRUG SELF ADMINISTRATION; DRUG STRUCTURE; FEMALE; GLYCOSYLATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SINGLE DRUG DOSE; THERMAL STIMULATION; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; PAIN MEASUREMENT; PHYSIOLOGY; PROCEDURES;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCOPEPTIDES; MACACA MULATTA; MALE; OPIOID PEPTIDES; PAIN MEASUREMENT; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 53849119185     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.138180     Document Type: Article

References (39)

1. Adams JU, Tallarida RJ, Geller EB, and Adler MW (1993) Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J Pharmacol Exp Ther 266:1261-1267.
2. Berger B, Rothmaier AK, Wedekind F, Zentner J, Feuerstein TJ, and Jackisch R (2006) Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br J Pharmacol 148:795-806.
3. Bilsky EJ, Egleton RD, Mitchell SA, Palian MM, Davis P, Huber JD, Jones H, Yamamura HI, Janders J, Davis TP, et al. (2000) Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J Med Chem 43:2586-2590.
4. Bowen CA, Fischer BD, Mello NK, and Negus SS (2002) Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys. J Pharmacol Exp Ther 302:264-273.
5. Brandt MR, Furness MS, Mello NK, Rice KC, and Negus SS (2001) Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther 296:939-946.
6. Butelman ER, Ball JW, Harris TJ, and Kreek MJ (2003) Topical capsaicin-induced allodynia in unanesthetized primates: pharmacological modulation. J Pharmacol Exp Ther 306:1106-1114.
7. Butelman ER, Harris TJ, and Kreek MJ (2004) Antiallodynic effects of loperamide and fentanyl against topical capsaicin-induced allodynia in unanesthetized primates. J Pharmacol Exp Ther 311:155-163.
8. Dykstra LA, Granger AL, Allen RM, Zhang X, and Rice KC (2002) Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl) 163:420-429.
9. Dykstra LA and Woods JH (1986) A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. J Pharmacol Methods 15:263-269.
10. Egleton RD, Bilsky EJ, Tollin G, Dhanasekaran M, Lowery JJ, Alves I, Davis P, Porreca F, Yamamura HI, Yeomans L, et al. (2005) Biousian glycopeptides penetrate the blood-brain barrier. Tetrahedron: Asymmetry 16:65-75.
11. Egleton RD, Mitchell SA, Huber JD, Palian MM, Polt R, and Davis TP (2001) Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation. J Pharmacol Exp Ther 299:967-972.
12. Elmagbari NO, Egleton RD, Palian MM, Lowery JJ, Schmid WR, Davis P, Navratilova E, Dhanasekaran M, Keyari CM, Yamamura HI, et al. (2004) Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides. J Pharmacol Exp Ther 311:290-297.
13. Gutstein H and Akil H (2005) Opioid analgesics, in The Pharmacological Basis of Therapeutics (Brunton L, Lazo J, and Parker K eds) pp 547-590, McGraw-Hill, New York.
14. Heyman JS, Vaught JL, Mosberg HI, Haaseth RC, and Porreca F (1989) Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2, D-Pen5]enkephalin. Eur J Pharmacol 165:1-10.
15. Hruby V and Mosberg HI (2004) Endogenous peptides for delta opioid receptors and analogues, in The Delta Receptor (Chang K-J, Porreca F and Woods JH eds) pp 159-174, Marcel Dekker, New York.
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
17. Kayser V, Chen YL, and Guilbaud G (1991) Behavioural evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in carrageenin-induced hyperalgesic rats. Brain Res 560:237-244.
18. Ko MC, Butelman ER, Traynor JR, and Woods JH (1998a) Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. J Pharmacol Exp Ther 285:518-526.
19. Ko MC, Butelman ER, and Woods JH (1998b) The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther 286:150-156.
20. Koob GF, Pettit HO, Ettenberg A, and Bloom FE (1984) Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J Pharmacol Exp Ther 229:481-486.
21. Lowery JJ, Yeomans L, Keyari CM, Davis P, Porreca F, Knapp BI, Bidlack JM, Bilsky EJ, and Polt R (2007) Glycosylation improves the central effects of DAMGO. Chem Biol Drug Des 69:41-47.
22. Mansour A, Khachaturian H, Lewis ME, Akil H, and Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314.
23. Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, and O'Donnell D (2003) Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465:349-360.
24. Negus SS, Burke TF, Medzihradsky F, and Woods JH (1993a) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903.
25. Negus SS, Butelman ER, Al Y, and Woods JH (1993b) Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys. J Pharmacol Exp Ther 266:1355-1363.
26. Negus SS, Gatch MB, Mello NK, Zhang X, and Rice K (1998) Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286:362-375.
27. Negus SS and Mello NK (2004) Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend 74:297-309.
28. Ohtsuki S and Terasaki T (2007) Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharmacol Res 24:1745-1758.
29. Sheldon RJ, Nunan L, and Porecca F (1989) Differential modulation of [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. J Pharmacol Exp Ther 249:462-469.
30. Stein C, Millan MJ, Shippenberg TS, Peter K, and Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248:1269-1275.
31. Stevenson GW, Folk JE, Rice KC, and Negus SS (2005) Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[({alpha}R)-{alpha}-((2S,5R)-4-Allyl- 2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide] and heroin. J Pharmacol Exp Ther 314:221-231.
32. Stevenson GW, Linsenmayer DC, Folk JE, Rice KC, and Negus SS (2003) Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociceptionn. J Pharmacol Exp Ther 307:1054-1064.
33. Valentino RJ, Herling S, Woods JH, Medzihradsky F, and Merz H (1981) Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists. J Pharmacol Exp Ther 217:652-659.
34. Vaught JL and Takemori AE (1979) Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J Pharmacol Exp Ther 208:86-90.
35. Walker EA, Butelman ER, DeCosta BR, and Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: Receptor mechanisms and temperature dependency. J Pharmacol Exp Ther 267:280-286.
36. Ward KW, Nagilla R, and Jolivette LJ (2005) Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica 35:191-210.
37. Ward KW and Smith BR (2004) A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. Drug Metab Dispos 32:612-619.
38. Woods JH and Schuster CR (1971) Opiates as reinforcing stimuli, in Stimulus Properties of Drugs (Thompson T and Pickens R eds) pp 163-175, Apple-Century-Crofts, New York.
39. Young AM and Woods JH (1982) Limitations on the antagonistic actions of opioid antagonists. Fed Proc 41:2333-2338.